TR201914034A2 - USAGE OF SCHISANDRIN B AS A DRUG CANDIDATE IN MULTIPLE SCLEROSIS DISEASE - Google Patents

USAGE OF SCHISANDRIN B AS A DRUG CANDIDATE IN MULTIPLE SCLEROSIS DISEASE

Info

Publication number
TR201914034A2
TR201914034A2 TR2019/14034A TR201914034A TR201914034A2 TR 201914034 A2 TR201914034 A2 TR 201914034A2 TR 2019/14034 A TR2019/14034 A TR 2019/14034A TR 201914034 A TR201914034 A TR 201914034A TR 201914034 A2 TR201914034 A2 TR 201914034A2
Authority
TR
Turkey
Prior art keywords
schisandrin
multiple sclerosis
usage
drug candidate
sclerosis disease
Prior art date
Application number
TR2019/14034A
Other languages
Turkish (tr)
Inventor
Eken Ahmet
Altuntaş Hami̇yet
Çakir Mustafa
Original Assignee
T C Erciyes Ueniversitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T C Erciyes Ueniversitesi filed Critical T C Erciyes Ueniversitesi
Priority to TR2019/14034A priority Critical patent/TR201914034A2/en
Publication of TR201914034A2 publication Critical patent/TR201914034A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş, Schisandrin B (Sch-B) etken maddesinin Multiple Sklerozis (MS) hastalığı tedavisinde ilaç adayı veya gıda takviyesi olarak kullanımı ile ilgilidir.The invention relates to the use of Schisandrin B (Sch-B) active ingredient as a drug candidate or food supplement in the treatment of Multiple Sclerosis (MS).

TR2019/14034A 2019-09-16 2019-09-16 USAGE OF SCHISANDRIN B AS A DRUG CANDIDATE IN MULTIPLE SCLEROSIS DISEASE TR201914034A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2019/14034A TR201914034A2 (en) 2019-09-16 2019-09-16 USAGE OF SCHISANDRIN B AS A DRUG CANDIDATE IN MULTIPLE SCLEROSIS DISEASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/14034A TR201914034A2 (en) 2019-09-16 2019-09-16 USAGE OF SCHISANDRIN B AS A DRUG CANDIDATE IN MULTIPLE SCLEROSIS DISEASE

Publications (1)

Publication Number Publication Date
TR201914034A2 true TR201914034A2 (en) 2021-04-21

Family

ID=76502943

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/14034A TR201914034A2 (en) 2019-09-16 2019-09-16 USAGE OF SCHISANDRIN B AS A DRUG CANDIDATE IN MULTIPLE SCLEROSIS DISEASE

Country Status (1)

Country Link
TR (1) TR201914034A2 (en)

Similar Documents

Publication Publication Date Title
MX2020008271A (en) Fap inhibitor.
BR112013028665A2 (en) tricyclic sulfonamide compounds and methods for making and using them
BR112013028666A2 (en) tricyclic pyrazolo sulfonamide compounds and methods for making and using the same
BR112014017673A8 (en) TRICYCLIC SULPHONAMIDE COMPOUNDS AND METHODS FOR MAKING AND USING THEM
EA201890654A1 (en) THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF THE HUMAN IMMUNODEFICIENCY VIRUS
CO6781497A2 (en) Treatment for lipodystrophy
EA201690687A1 (en) REPLICATION INHIBITORS OF THE VIRUS OF IMMUNODEFICIENCY
BR112014017780A8 (en) TRICYCLIC SULPHONE COMPOUNDS AND METHODS FOR MAKING AND USING THEM
CL2021001388A1 (en) Useful compounds in hiv therapy
CO2021012579A2 (en) Useful compounds in hiv therapy
EA201890532A1 (en) NEW ANNELED BENZAMIDES
EA201791696A1 (en) COMPOSITION FOR THE TREATMENT OF VENO-ACCLUSION DISEASE OF THE LIVER
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
GEP20237486B (en) Formulations of copanlisib
EA201992117A1 (en) PHARMACEUTICAL COMBINATION CONTAINING A PRESIMOD
EA201992389A1 (en) SUBSTITUTED N-ARILETHYL-2-AMINOCHINOLIN-4-CARBOXAMIDES AND THEIR APPLICATION
MX2019002901A (en) Treatment of multiple sclerosis with chs-131.
EA201890929A1 (en) LOW DOSES OF DIPYRIDAMOL COMPOSITIONS FOR ORAL ADMINISTRATION AND THEIR USE
TR201914043A1 (en) EFERVESAN TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
TR201914034A2 (en) USAGE OF SCHISANDRIN B AS A DRUG CANDIDATE IN MULTIPLE SCLEROSIS DISEASE
MY197518A (en) Preventive and/or therapeutic agent of immune disease
TR201914037A2 (en) THE USE OF ALANTOLACTON AS A DRUG CANDIDATE IN MULTIPLE SCLEROSIS DISEASE
EA201990162A1 (en) PHARMACEUTICAL COMPOSITIONS
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.